Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2011 1
2012 3
2013 3
2014 7
2015 8
2016 13
2017 6
2018 10
2019 8
2020 10
2021 3
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

64 results
Results by year
Filters applied: . Clear all
Page 1
Targeted therapies in pulmonary arterial hypertension.
Montani D, Chaumais MC, Guignabert C, Günther S, Girerd B, Jaïs X, Algalarrondo V, Price LC, Savale L, Sitbon O, Simonneau G, Humbert M. Montani D, et al. Among authors: algalarrondo v. Pharmacol Ther. 2014 Feb;141(2):172-91. doi: 10.1016/j.pharmthera.2013.10.002. Epub 2013 Oct 14. Pharmacol Ther. 2014. PMID: 24134901 Free article. Review.
Cardiac Overexpression of PDE4B Blunts β-Adrenergic Response and Maladaptive Remodeling in Heart Failure.
Karam S, Margaria JP, Bourcier A, Mika D, Varin A, Bedioune I, Lindner M, Bouadjel K, Dessillons M, Gaudin F, Lefebvre F, Mateo P, Lechène P, Gomez S, Domergue V, Robert P, Coquard C, Algalarrondo V, Samuel JL, Michel JB, Charpentier F, Ghigo A, Hirsch E, Fischmeister R, Leroy J, Vandecasteele G. Karam S, et al. Among authors: algalarrondo v. Circulation. 2020 Jul 14;142(2):161-174. doi: 10.1161/CIRCULATIONAHA.119.042573. Epub 2020 Apr 8. Circulation. 2020. PMID: 32264695
Potassium Channel Remodeling in Heart Disease.
Algalarrondo V, Nattel S. Algalarrondo V, et al. Card Electrophysiol Clin. 2016 Jun;8(2):337-47. doi: 10.1016/j.ccep.2016.01.006. Epub 2016 Mar 18. Card Electrophysiol Clin. 2016. PMID: 27261825 Review.
FAP neuropathy and emerging treatments.
Adams D, Théaudin M, Cauquil C, Algalarrondo V, Slama M. Adams D, et al. Among authors: algalarrondo v. Curr Neurol Neurosci Rep. 2014 Mar;14(3):435. doi: 10.1007/s11910-013-0435-3. Curr Neurol Neurosci Rep. 2014. PMID: 24482069 Review.
Current and future treatment of amyloid neuropathies.
Adams D, Cauquil C, Theaudin M, Rousseau A, Algalarrondo V, Slama MS. Adams D, et al. Among authors: algalarrondo v. Expert Rev Neurother. 2014 Dec;14(12):1437-51. doi: 10.1586/14737175.2014.983905. Epub 2014 Nov 21. Expert Rev Neurother. 2014. PMID: 25416603 Review.
Prophylactic implantable cardioverter-defibrillator in the very elderly.
Zakine C, Garcia R, Narayanan K, Gandjbakhch E, Algalarrondo V, Lellouche N, Perier MC, Fauchier L, Gras D, Bordachar P, Piot O, Babuty D, Sadoul N, Defaye P, Deharo JC, Klug D, Leclercq C, Extramiana F, Boveda S, Marijon E. Zakine C, et al. Among authors: algalarrondo v. Europace. 2019 Jul 1;21(7):1063-1069. doi: 10.1093/europace/euz041. Europace. 2019. PMID: 30891608
Indications of anti-inflammatory drugs in cardiac diseases.
Algalarrondo V, Boycott H, Eliahou L, Mabille M, Slama MS. Algalarrondo V, et al. Antiinflamm Antiallergy Agents Med Chem. 2013;12(1):3-13. doi: 10.2174/1871523011312010003. Antiinflamm Antiallergy Agents Med Chem. 2013. PMID: 23286286 Review.
Implantable cardiac defibrillator leads dysfunction after LVAD implantation.
Galand V, Leclercq C, Bourenane H, Boulé S, Vincentelli A, Maury P, Mondoly P, Picard F, Welté N, Kindo M, Cardi T, Pasquié JL, Gaudard P, Gourraud JB, Probst V, Defaye P, Boignard A, Para M, Algalarrondo V, Pelcé E, Gariboldi V, Pozzi M, Obadia JF, Anselme F, Litzler PY, Blanchart K, Babatasi G, Garnier F, Bielefeld M, Hamon D, Lellouche N, Bourguignon T, Pierre B, Eschalier R, D'Ostrevy N, Varlet E, Marijon E, Blangy H, Sadoul N, Flécher E, Martins RP. Galand V, et al. Among authors: algalarrondo v. Pacing Clin Electrophysiol. 2020 Nov;43(11):1309-1317. doi: 10.1111/pace.14004. Epub 2020 Jul 24. Pacing Clin Electrophysiol. 2020. PMID: 32627211
64 results